Off-market insider buying at Blueberries Medical (BBM)

Off-market insider buying at Blueberries Medical (C:BBM)

Facundo Garreton, a Director, acquired 54,498,889 Common Shares on an indirect ownership basis for registered holder Terraflos Inc. at a price of $0.027 through a prospectus or prospectus exempt offering on November 28th, 2022. This represents a $1,471,470 investment into the company's shares and an account share holdings change of greater than 100%.

Blueberries Medical is in the Drug Retailers Sub Industry Group under the Consumer Non-Cyclicals Sector.

Blueberries Medical Corp. (Blueberries) is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the cultivation and development of medicinal cannabis and related products. The Company is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries are also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis. Its geographical segment includes Colombia, Canada and Panama. The Company's subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN).